Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia

被引：0
|
作者：
Koh, KK
Han, SH
Quon, MJ
Chung, WJ
Shin, MS
Ahn, TH
Choi, IS
Shin, EK
机构：
[1] Gachon Med Sch, Inchon, South Korea
[2] NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：394A / 394A
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of a new hydroxymethylglutaryl-coenzyme a reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: Comparison with fenofibrate
    Ooi, TC
    Heinonen, T
    Alaupovic, P
    Davignon, J
    Leiter, L
    Lupien, PJ
    Sniderman, AD
    Tan, MH
    Tremblay, G
    Sorisky, A
    Shurzinske, L
    Black, DM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) : 1793 - 1799
  • [32] EFFECTS OF ATORVASTATIN-FENOFIBRATE COMBINATION COMPARED TO ATORVASTATIN MONOTHERAPY ON LIPID PROFILE IN PATIENTS WITH COMBINED DYSLIPIDEMIA
    Derosa, G.
    Salvadeo, S.
    Ferrari, I.
    Cicero, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [33] A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia
    McKenney, JM
    McCormick, LS
    Weiss, S
    Koren, M
    Kafonek, S
    Black, DM
    AMERICAN JOURNAL OF MEDICINE, 1998, 104 (02): : 137 - 143
  • [34] Effects of atorvastatin on fasting and postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidemia
    Boquist, S
    Karpe, F
    Danell-Toverud, K
    Hamsten, A
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 315A - 315A
  • [35] The long-term treatment of combined hyperlipidemia in CHD patients with a combination of fluvastatin and fenofibrate
    Widimsky, J
    Hulínsky, V
    Balazovjech, I
    Lánská, V
    ATHEROSCLEROSIS, 1999, 144 : 181 - 181
  • [36] Beneficial effects of atorvastatin in the treatment of hyperlipidemia after renal transplantation
    Demetriou, D
    Shabpar, A
    Böhmig, G
    Schmaldienst, S
    Hörl, WH
    Watschinger, B
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (08) : 358 - 361
  • [37] Additive beneficial effects of ramipril combined with sirinvastatin in the treatment of type II diabetic patients
    Kon, K
    Han, SH
    Quon, MJ
    Shin, MS
    Ahn, TH
    CIRCULATION, 2004, 110 (17) : 811 - 811
  • [38] Additive beneficial effects of ramipril combined with simvastatin in the treatment of type II diabetic patients
    Koh, K. K.
    Han, S. H.
    Quon, M. J.
    Chung, W. -J.
    Shin, E. K.
    EUROPEAN HEART JOURNAL, 2005, 26 : 294 - 294
  • [39] Atorvastatin and micronized fenofibrate, alone and in combination, in type-2 diabetes mellitus with combined hyperlipidemia
    Athyros, V
    Papageorgiou, AA
    Athyrou, VV
    Demitriadis, DS
    Kontopoulos, AG
    EUROPEAN HEART JOURNAL, 2002, 23 : 170 - 170
  • [40] Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL
    Winkler, K
    Weltzien, P
    Friedrich, I
    Schmitz, H
    Nickell, HH
    Hoffmann, MM
    Baumstark, MW
    Wieland, H
    März, W
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2004, 112 (05) : 241 - 247
12345